Chapter 23: Disorders of Red Blood Cells

The content integrates discussion of clinical transfusion medicine, including the selection, preparation, and administration of blood products for therapeutic intervention. A central focus involves autoimmune hemolytic anemia, a condition in which the patient's own immune system attacks and destroys erythrocytes. The chapter distinguishes between distinct immunological mechanisms underlying this disease, including warmimmunoglobulin antibody-mediated hemolysis, cold-reactive antibody disease presenting with agglutination at lower temperatures, and drug-induced immune responses that compromise red blood cell survival. Beyond immune-mediated destruction, the chapter emphasizes the critical role of nutritional factors in maintaining erythrocyte health and preventing anemia. Specific clinical guidance addresses the importance of iron supplementation in infants, recognizing that adequate iron availability is essential for hemoglobin synthesis and normal red blood cell development. The chapter similarly stresses the necessity of sufficient folic acid intake, as this vitamin cofactor is required for deoxyribonucleic acid synthesis and cell division in erythroid progenitor cells. Additionally, vitamin D status receives attention for its broader role in mineral homeostasis and bone health, with implications for overall hematologic function. Together, these topics provide a comprehensive framework for understanding how red blood cell disorders arise through multiple mechanisms and how clinical intervention through transfusion medicine and nutritional support can address these conditions in patient populations.